NumFin

Chong Kun Dang Pharmaceutical Corp.

符号: 185750.KS

KSC

101200

KRW

今天的市场价格

  • 6.5327

    市盈率

  • 0.2409

    PEG比率

  • 1.29T

    MRK市值

  • 0.01%

    DIV收益率

Chong Kun Dang Pharmaceutical Corp. (185750-KS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Chong Kun Dang Pharmaceutical Corp. (185750.KS). 的默认数据。公司收入显示 979923.666 M 的平均值，即 0.555 % 增长率。整个期间的平均毛利润为 389538.279 M，即 0.671 %. 平均毛利率为 0.421 %. 公司去年的净收入增长率为 1.625 %，等于 1.459 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Chong Kun Dang Pharmaceutical Corp. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.247. 在流动资产领域，185750.KS 的报告货币为946571.861. 这些资产中的很大一部分，即 365065.296 是现金和短期投资。与去年的数据相比，该部分的变化率为1.342%. 公司的长期投资虽然不是其重点，但以报告货币计算的67179.09（如果有的话）为67179.09。这表明与上一报告期相比，1107.072% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 30000. 这一数字表明，-1.000% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 815694.495. 这方面的年同比变化率为 0.311%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为311468.61，存货估值为 261431.89，商誉估值为 0（如有. 无形资产总额（如果有）按 52527.15 估值. 应付账款和短期债务分别为 183938.77 和 184767.37. 债务总额为219763.88，债务净额为 117.53. 其他流动负债为 134996.55，加上总负债 586793.27. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013

balance-sheet.row.cash-and-short-term-investments

977306.91365065.3155861.2187332.6
161855.4
92373.2
45948.7
45471.2
21720.8
12853
51350.8
16276.6

balance-sheet.row.short-term-investments

234574.58145418.938444.355519.9
38196.3
15450.7
0
0
0
0
2580
3120

balance-sheet.row.net-receivables

1166084.87311468.6287306.6234703.7
226958.6
205590.1
216791.7
216913
218776
185529.6
171848.2
167870.6

balance-sheet.row.inventory

1101639.04261431.9270081.5224722.9
185565.2
148453.7
127590.7
104338.7
98260.5
89982.7
75236.2
71155.4

balance-sheet.row.other-current-assets

9554.788606.1365.520387.9
25734.9
24718
0
181.3
0
0
0
0

balance-sheet.row.total-current-assets

3254585.6946571.9713614.8667147.2
600114.1
471135
390331.1
366904.2
338757.3
288365.4
298435.2
255302.6

balance-sheet.row.property-plant-equipment-net

1263852.99319787.1310697.4298909.7
274650.3
263086.3
254109.3
252376.7
244675.5
228026.5
215240.3
214686.3

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

176043.6452527.12695320805.5
19032.5
15915
15375.9
14333.8
14858.3
15843.7
16073.6
17833.6

balance-sheet.row.goodwill-and-intangible-assets

176043.6452527.12695320805.5
19032.5
15915
15375.9
14333.8
14858.3
15843.7
16073.6
17833.6

balance-sheet.row.long-term-investments

110109.367179.15565.5-22146.7
-11632.1
9641.6
0
0
0
0
14487.8
5937

balance-sheet.row.tax-assets

35440.2714213.26208.62350.3
63996.8
41402.7
0
0
0
0
26690.5
25350.3

balance-sheet.row.other-non-current-assets

186897.572150.161843.579634.1
171.5
171.5
51678.6
43590.6
43407.7
44051.1
2826.6
2841.3

balance-sheet.row.total-non-current-assets

1772343.77455856.6411268379552.9
346219
330217.1
321163.8
310301.1
302941.5
287921.3
275318.9
266648.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

5026929.371402428.41124882.81046700.1
946333.1
801352.1
711494.9
677205.3
641698.9
576286.7
573754.1
521951.2

balance-sheet.row.account-payables

677227.23183938.8145436.3129327.4
144120.1
101969.5
68592
71181.4
71204.3
49529.3
40051.2
34407.2

balance-sheet.row.short-term-debt

615980.74184767.4124445.5102091.4
78632.1
92213
58578
81100
84567
53967
80600
63567

balance-sheet.row.tax-payables

130003.7843938.229026.418701.1
29209.6
19461
21695.8
24172.2
20840.4
13544.6
10136.6
3722.1

balance-sheet.row.long-term-debt-total

301223.1330000111292.6134962.3
57509.2
25845.3
45892.1
21358.2
40000
70600
43967
61000

Deferred Revenue Non Current

14490.661484.86438.35982
13290.9
21309
0
0
0
0
0
25019.9

balance-sheet.row.deferred-tax-liabilities-non-current

21900.45---
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

286154.11134996.698922.320691.5
20802.7
19255
55643.4
0
34830.5
34401.9
30529.7
29156.7

balance-sheet.row.total-non-current-liabilities

395681.8575327.4129380.9160660.6
74119.5
49329.9
76086.1
49862.7
76006.2
110282.8
80988.9
92974.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

31147.984996.51694.23470.5
5161.5
7014.6
0
0
0
0
0
0

balance-sheet.row.total-liab

2153650.5586793.3503594480890.4
394740.3
326398.9
280595.3
273910.4
287448.5
261725.6
242306.4
223827.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

125684.6431421.229970.128565.2
27214.2
25925.7
24698.1
23522.6
23522.6
23522.6
23522.6
23522.6

balance-sheet.row.retained-earnings

1554612.31218102.4376370.8302106.6
272194.1
184629
142550.9
106031.1
58888.9
19533.3
34568.9
3456.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

1404661.23350829.8276706.4250156.9
173748.2
130262.5
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-210144.4215341.1-60654.3-14818.7
78270.3
132702.9
261476.2
272161.1
271838.9
271505.1
273356.1
271144.2

balance-sheet.row.total-stockholders-equity

2874813.78815694.5622393.1566010
551426.8
473520.1
428725.1
401714.9
354250.4
314561.1
331447.7
298123.7

balance-sheet.row.total-liabilities-and-stockholders-equity

5026929.371402428.41124882.81046700.1
946333.1
801352.1
711494.9
677205.3
641698.9
576286.7
573754.1
521951.2

balance-sheet.row.minority-interest

-1534.92-59.3-1104.3-200.3
166
1433.1
2174.4
1580.1
0
0
0
0

balance-sheet.row.total-equity

2873278.86815635.2621288.8565809.6
551592.8
474953.2
430899.6
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

5026929.37---
-
-
-
-
-
-
-
-

Total Investments

344683.8821259844009.833373.2
26564.2
25092.3
24831.7
17839.3
18513.8
15547.7
17067.8
9057

balance-sheet.row.total-debt

922200.38219763.9235738.1237053.8
136141.3
118058.3
104470.1
102458.2
124567
124567
124567
124567

balance-sheet.row.net-debt

179468.05117.5118321.2105241.1
12482.3
41135.7
58521.4
56987
102846.2
111714
75796.2
111410.4

现金流量表

在 Chong Kun Dang Pharmaceutical Corp. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -1.000 的转变。该公司最近通过发行 -3335.33 扩大了股本，与上一年相比出现了4.842 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-171312903890.000. 与上一年相比， 1.620 发生了变化. 在同一时期，公司记录了 36942.22, 39.75 和 -22714.6，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-11608.53 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -16.53，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013

cash-flows.row.net-income

213740.93212521.279977.842356.5
90404.9
52975.3
41704.4
53728.3
40946.1
-6772.7
35153.7
4417

cash-flows.row.depreciation-and-amortization

37007.9636942.233597.727481.9
23785.6
23052.4
21218
21985.3
23933.6
22677.3
20548
3280.4

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

29681.8429681.8-77299.3-71568.7
-51482.9
-21554.3
-41438.1
-21599.2
-36176.6
-26701.6
-5963
426.3

cash-flows.row.account-receivables

-29559.69-29559.7-51435.9-6926
-21894
10832.8
0
0
0
0
0
0

cash-flows.row.inventory

-5980.26-5980.3-54466.2-53770.6
-46240.1
-48845.1
-30802.9
-19587.6
-17639.5
-19504.8
-5926.8
3998.9

cash-flows.row.account-payables

38583.7838583.815824.5-15597.8
42358
33400.7
0
0
0
0
0
0

cash-flows.row.other-working-capital

26638.012663812778.24725.7
-25706.8
-16942.8
-10635.1
-2011.6
-18537.1
-7196.8
-36.2
-3572.5

cash-flows.row.other-non-cash-items

37729.1739014.731458.414634.2
41616.1
22817.2
21143.4
27558.5
29083
18069
14852
1836

cash-flows.row.net-cash-provided-by-operating-activities

318159.91000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-68806.05-68806-53064.7-51844.4
-36817.7
-24861.9
-24640.2
-21322.2
-39439.5
-35673.2
-21324.3
-2118.9

cash-flows.row.acquisitions-net

20636.77451.6142.1-3448.7
-4109.9
-2690.6
0
71.6
-3076.4
-2096.6
-2499.5
0

cash-flows.row.purchases-of-investments

-192468.23-192468.2-57181.1-61266.4
-59956.7
-17051.7
-6204.2
-20241
-1147.7
-1663.7
-7992.7
-447.7

cash-flows.row.sales-maturities-of-investments

89470.048947044375.621934.7
32516.4
1800
0
17031.7
-1205.9
3096
3440
0

cash-flows.row.other-investing-activites

-20145.4339.8347.83815.5
4446.8
3077.4
509.4
579.6
1471.6
407.6
2588.1
175.1

cash-flows.row.net-cash-used-for-investing-activites

-171312.9-171312.9-65380.3-90809.3
-63921.1
-39726.7
-30335
-23880.3
-43397.8
-35929.9
-25788.5
-2391.4

cash-flows.row.debt-repayment

-44714.6-22714.6-0.3-896.2
-61966.1
-11831.3
-75035.6
-43467
-77500
-10000
-1600
0

cash-flows.row.common-stock-issued

0-3335.300
0
0
1358.2
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-6024.99-6025-1888.4-1935.3
-2078
-442.9
-6950.2
0
0
0
0
-383.6

cash-flows.row.dividends-paid

0-11608.5-11238.8-10808.3
-9277.1
-8839
-8463.3
-8463.3
-5642.2
-7523
-2821.1
0

cash-flows.row.other-financing-activites

18648.14-16.5-3212.498778.7
80390
14525.1
77353.9
17198.9
77500
10000
1600
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-43699.98-43700-16339.885138.9
7068.8
-6588.1
-11737
-34731.5
-5642.2
-7523
-2821.1
-383.6

cash-flows.row.effect-of-forex-changes-on-cash

-917.57-917.6-410.1920.1
-734.9
-1.9
-78.3
689.3
121.8
263
-366.8
-17.2

cash-flows.row.net-change-in-cash

102229.45102229.4-14395.88153.6
46736.6
30973.8
477.5
23750.4
8867.9
-35917.9
35614.2
7167.4

cash-flows.row.cash-at-end-of-period

742732.33219646.3117416.9131812.7
123659.1
76922.5
45948.7
45471.2
21720.8
12853
48770.8
13156.6

cash-flows.row.cash-at-beginning-of-period

640502.88117416.9131812.7123659.1
76922.5
45948.7
45471.2
21720.8
12853
48770.8
13156.6
5989.1

cash-flows.row.operating-cash-flow

318159.91318159.967734.512903.9
104323.7
77290.6
42627.8
81672.8
57786.1
7272
64590.7
9959.7

cash-flows.row.capital-expenditure

-68806.05-68806-53064.7-51844.4
-36817.7
-24861.9
-24640.2
-21322.2
-39439.5
-35673.2
-21324.3
-2118.9

cash-flows.row.free-cash-flow

249353.86249353.914669.8-38940.5
67506
52428.7
17987.6
60350.7
18346.7
-28401.2
43266.4
7840.9

利润表行

Chong Kun Dang Pharmaceutical Corp. 的收入与上期相比变化了 0.122%。据报告, 185750.KS 的毛利润为 655344.55。该公司的营业费用为 408657.61，与上年相比变化了 -5.564%. 折旧和摊销费用为 36942.22，与上一会计期间相比变化了 0.058%. 营业费用报告为 408657.61，显示-5.564% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长1.244%. 营业收入为 246686.94，与上年相比变化了1.245%. 净利润的变化率为 1.625%。去年的净收入为212521.17.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013

income-statement-row.row.total-revenue

1657673.311669404.41488344.71343559.4
1303005.5
1079337.7
956218.9
884362.8
831985.5
592493.5
544129.8
86318.2

income-statement-row.row.cost-of-revenue

779200.121014059.9945705.3847741.1
813865.7
675059.1
575815.6
524706.5
497098.9
296312.1
263788.5
40086.5

income-statement-row.row.gross-profit

878473.19655344.5542639.4495818.3
489139.8
404278.6
380403.3
359656.3
334886.6
296181.3
280341.2
46231.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

104406.15---
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

199875.81---
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

80977.59---
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-716317.4-11694.4139957.4135069
127170.6
132350.1
-3984.2
811.8
2302.2
-21793.2
-687.7
-382.6

income-statement-row.row.operating-expenses

249710.32408657.6432733.3401059.6
365203.9
329702.9
304663.4
281891.4
273637.1
253476.2
226411
38692.7

income-statement-row.row.cost-and-expenses

1222350.411422717.51378438.71248800.7
1179069.6
1004762
880479
806597.8
770736
549788.4
490199.5
78779.2

income-statement-row.row.interest-income

4775.615789.32139716.2
1282.7
854.5
584.7
609.5
144
649.5
942.4
60.3

income-statement-row.row.interest-expense

7001.1292716846.94029.9
3870.9
3150.5
2712.2
3509.9
4171.3
4352.7
5367.1
950.6

income-statement-row.row.selling-and-marketing-expenses

80977.59---
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

1.88-5283.9-12741-14164.8
-2096.9
-2754.4
-7399.5
-3165.8
-4461.8
-27567.4
-5448.1
-1531.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-716317.4-11694.4139957.4135069
127170.6
132350.1
-3984.2
811.8
2302.2
-21793.2
-687.7
-382.6

income-statement-row.row.total-operating-expenses

1.88-5283.9-12741-14164.8
-2096.9
-2754.4
-7399.5
-3165.8
-4461.8
-27567.4
-5448.1
-1531.6

income-statement-row.row.interest-expense

7001.1292716846.94029.9
3870.9
3150.5
2712.2
3509.9
4171.3
4352.7
5367.1
950.6

income-statement-row.row.depreciation-and-amortization

202519.1236942.234919.318187.3
26502.5
25946.8
21218
21985.3
23933.6
22677.3
20548
3280.4

income-statement-row.row.ebitda-caps

444402.06---
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

241882.93246686.9109906.194758.7
123935.9
74575.6
75739.9
77765
61249.5
42705.1
53930.2
7539

income-statement-row.row.income-before-tax

241884.8224140397165.180593.9
121839
71821.2
68340.3
74599.2
56787.7
15137.6
48482.1
6007.4

income-statement-row.row.income-tax-expense

39271.8927995.717187.338237.4
31434.1
18845.9
26635.9
20870.9
15841.6
21910.4
13328.4
1590.4

income-statement-row.row.net-income

201766.15212521.280953.442720.4
91632.8
53881.6
42398.5
53807.2
40946.1
-6772.7
35153.7
4417
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
545.25 INR
BSE
ERIS.NS
Eris Lifesciences Limited.
873.35 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.616 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1003.8 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13790 KRW
KSC

常见问题

什么是 Chong Kun Dang Pharmaceutical Corp. (185750.KS) 总资产是多少？

Chong Kun Dang Pharmaceutical Corp. (185750.KS) 总资产为 1402428435512.000.

什么是企业年收入？

年收入为 858061047502.000.

企业利润率是多少？

公司利润率为 0.530.

什么是公司自由现金流？

自由现金流为 19599.181.

什么是企业净利润率？

净利润率为 0.122.

企业总收入是多少？

总收入为 0.146.

什么是 Chong Kun Dang Pharmaceutical Corp. (185750.KS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 212521171440.000.

公司总债务是多少？

债务总额为 219763880100.000.

营业费用是多少？

运营支出为 408657610015.000.

公司现金是多少？

企业现金为 219646348416.000.